Clinical Trials on Koronar restenose

Total 8074 results

Medical University of Silesia

Completed

PCI vs. CABG in UPLM-ISR (LM-DRAGON)

Left Main Coronary Artery Disease | Restenosis, Coronary | PTCA Left Main Artery Complications

Poland, Italy
Fundación EPIC

Active, not recruiting

Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR (iLITRO)

Coronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, Coronary

Spain
Deutsches Herzzentrum Muenchen
Abbott; EvidentIQ Germany GmbH; Institute of AI and Informatics in Medicine Technical...

Recruiting

Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5 (ISAR-DESIRE5)

Coronary Artery Disease | Restenoses, Coronary

Germany
Silesian Centre for Heart Diseases

Unknown

Metal Allergy In-Stent Restenosis Study (RESTALL)

Coronary Artery Disease | Restenoses, Coronary | In-stent Restenosis | Contact Allergy | Metal Allergy
Biotronik AG

Terminated

BIOFLOW-SV All Comers Registry (BIOFLOW-SV)

Restenoses, Coronary | de Novo | Symptomatic Ischemic Heart Disease

Brazil
Abbott Medical Devices

Recruiting

Abbott Vascular Medical Device Registry (AV-MDR)

Acute Myocardial Infarction | Restenoses, Coronary | Coronary Artery Lesions | Venous Embolism | Arterial Embolism

United States, China, Hungary, Spain, Germany, Austria, Australia, Belgium, France, Italy, Netherlands, Switzerland, Taiwan, United Arab Emirates
Medstar Health Research Institute

Withdrawn

REWARDS- In-stent Restenosis

In-Stent Coronary Artery Restenosis

United States
Medstar Health Research Institute

Unknown

Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since Implantation

In-stent Coronary Artery Restenosis

United States
Biotronik AG

Completed

Paclitaxel Releasing Balloon in Patients Presenting With In-Stent Restenosis (PEPPER)

In-stent Coronary Artery Restenosis

Germany
B. Braun Medical Inc.
Infraredx; Bright Research Partners

Withdrawn

Resveratrol Excipient Paclitaxel Coated Balloon for Coronary Treatment (RESPECT-ISR)

Coronary Artery Restenosis | In-stent Restenosis | In-stent Coronary Artery Restenosis
Rambam Health Care Campus

Completed

In-stent Restenosis in Patients With Patent Previous Bare Metal Stent

In-stent Coronary Artery Restenosis

Israel
B. Braun Medical International Trading Company...

Completed

A Safety and Efficacy Study of Paclitaxel-eluting Balloon to Paclitaxel-eluting Stent (PEPCAD)

Coronary Instent Restenosis

China
Semmelweis University Heart and Vascular Center

Recruiting

Optimal Treatment for Coronary Drug Eluting Stent In-stent Restenosis (OPEN-ISR)

Coronary Stent Restenosis

Hungary
Spanish Society of Cardiology
Abbott Medical Devices; Terumo Medical Corporation; Fundación de Investigación... and other collaborators

Unknown

Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI) (RIBS VI)

Coronary In-stent Restenosis

Spain
Jesse Brown VA Medical Center

Unknown

SOLEMN Study - Synergy Optical Coherence Tomography in Left Main PCI (SOLEMN)

Percutaneous Coronary Intervention | Optical Coherence Tomography | In-stent Coronary Artery Restenosis

United States
Ospedale Santa Maria Goretti

Withdrawn

Prognostic Assessment of Different Pattern of Bifurcation Restenosis (LATINA)

In-stent Coronary Artery Restenosis

Italy
MINVASYS
European Cardiovascular Research Center

Completed

Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in In-Stent Restenosis Lesions (DEBREST) (DEBREST)

In-stent Coronary Artery Restenosis

France
Second Affiliated Hospital, School of Medicine,...
West China Hospital; The Third Xiangya Hospital of Central South University; Shanghai... and other collaborators

Unknown

Evaluation of the Efficacy and Safety of a Paclitaxel Eluting PTCA Balloon Catheter in Coronary In-stent Restenosis

Coronary In-stent Restenosis

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Not yet recruiting

Trial for MicroPort's DCB

Coronary Artery In-stent Restenosis
DK Medical Technology (Suzhou) Co., Ltd.
Core Medical (Beijing) Co., Ltd.

Active, not recruiting

A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary In-stent Restenosis

Coronary In-stent Restenosis

China
Spanish Society of Cardiology
Abbott Medical Devices; Fundación de Investigación Biomédica - Hospital Universitario... and other collaborators

Unknown

Restenosis Intrastent: Treatment of Bioresorbable Vascular Scaffolds Restenosis (RIBS VII)

Coronary In-stnent Restenosis

Spain
Abbott Medical Devices

Completed

EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease (EXecutive)

Coronary Artery Disease | Coronary Disease | Coronary Artery Stenosis | Coronary Artery Restenosis

Italy
Abbott Medical Devices

Completed

EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease (EXecutive)

Coronary Artery Disease | Coronary Disease | Coronary Artery Stenosis | Coronary Artery Restenosis

Italy
Hadassah Medical Organization

Unknown

Effect of Metal Skin Sensitivity on Restenosis After Stent Implantation

Coronary Stent Restenosis

Israel
Best Vascular, Inc.

Unknown

Retrospective Long-term Safety and Efficacy Study of the Beta-Cath(TM) 3.5F System

Coronary In-stent Restenosis

United States
Abbott Medical Devices

Completed

ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients.

Coronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery Restenosis

Belgium
Peking Union Medical College Hospital

Not yet recruiting

Disease Characteristics of IR-CAD: a Case-control Study

Coronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation Vascular

China
Abbott Medical Devices

Completed

XIENCE V: SPIRIT WOMEN

Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery Restenosis

France, Italy, Norway, China, Spain, Germany, United Kingdom, Switzerland, Israel, Denmark, Belgium, Austria, Poland, Australia, Portugal, Argentina, Brazil, Hungary, Latvia, Netherlands, India, Greece, Malaysia, Russian Federation, South... and more
Abbott Medical Devices

Completed

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Myocardial Ischemia | Coronary Artery Disease | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Stents | Total Coronary Occlusion | Coronary Artery Restenosis

United States
Abbott Medical Devices

Completed

XIENCE V: SPIRIT WOMEN Sub-study

Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery Restenosis

Italy, Norway, Switzerland, Denmark, Spain, Poland, Belgium, Argentina, Austria, Brazil, France, Germany, Hungary, Latvia, Netherlands
Peking Union Medical College Hospital

Recruiting

Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study

Coronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation Vascular

China
Biosensors Europe SA
European Cardiovascular Research Center

Unknown

A Randomized Clinical Evaluation of the BioFreedom™ Stent (Leaders Free)

Bleeding | Stable Angina | In-stent Coronary Artery Restenosis | Ischemic Heart Disease Silent | ST Elevation (STEMI) and Non-ST Elevation (NSTEMI) Myocardial Infarction

Switzerland
University Hospital, Saarland

Completed

Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR I)

Coronary Restenosis

Germany
University Hospital Ostrava

Completed

Treatment of In-Stent Restenosis 2 Study (TIS2)

Coronary Restenosis

Czechia
InnoRa GmbH

Completed

Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon

Coronary Restenosis

Switzerland, Germany
Deutsches Herzzentrum Muenchen

Completed

Trial of a Novel Paclitaxel-coated Balloon With Citrate Excipient for Restenosis in -Limus Analogue DES (ISAR-DESIRE 3A)

Coronary Restenosis

Germany
The Cleveland Clinic

Completed

Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal

Coronary Restenosis

United States
Boston Scientific Corporation

Completed

Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis (TAXUS V ISR)

Coronary Restenosis

United States, Canada
Deutsches Herzzentrum Muenchen

Completed

Oral Sirolimus for In-Stent Restenosis (OSIRIS)

Coronary Restenosis

Germany
Seung-Jung Park
CardioVascular Research Foundation, Korea

Terminated

Drug-eluting Stents vs. Drug-coated Balloon for Preventing Recurrent In-stent Restenosis (RESTORE)

Coronary Restenosis

Korea, Republic of
Celgene Corporation

Completed

Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis (SNAPIST-III)

Coronary Restenosis
Abbott Medical Devices

Completed

Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period (XERES)

Coronary Restenosis

France
Seoul National University Hospital

Unknown

Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial (mini-COREA)

Angioplasty, Transluminal, Percutaneous Coronary | Coronary Restenosis

Korea, Republic of
M.A. Med Alliance S.A.
Iqvia Pty Ltd

Recruiting

SELUTION SLR™ 014 In-stent Restenosis (SELUTION4ISR)

Coronary Restenosis

United States, France, Brazil, Italy, Netherlands, Belgium
ZhuHai Cardionovum Medical Device Co., Ltd.
R&G Pharma Studies Co.,Ltd.

Completed

Compare the Efficacy and Safety of RESTORE DEB and SeQuent® Please in Chinese Patient With Coronary In-stent Restenosis

Coronary Restenosis

China
Mitsui Memorial Hospital
Teikyo University; Tokai University

Unknown

Effect of Combination of Non-sLip Element Balloon (NSE) and druG-coated bAlloon (DCB) for In-steNT Restenosis Lesions (ELEGANT)

Coronary Restenosis

Japan
Aziende Chimiche Riunite Angelini Francesco S.p.A

Completed

The Effects of Bindarit in Preventing Stent Restenosis

Coronary Restenosis

Italy
Sahajanand Medical Technologies Pvt. Ltd.
CMS Medical

Completed

Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT)

Coronary Restenosis

Brazil
The University of Hong Kong

Completed

EGO-COMBO Clinical End-point Extension Study Beyond 36 Months

Coronary Restenosis

China
University Hospital, Saarland

Completed

Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR II)

Coronary Restenosis

Germany

Clinical Trials on Koronar restenose

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations